200 related articles for article (PubMed ID: 32070860)
21. Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies.
Hanna C; Kwok L; Finlay-Schultz J; Sartorius CA; Cittelly DM
J Vis Exp; 2016 Nov; (117):. PubMed ID: 27929464
[TBL] [Abstract][Full Text] [Related]
22. Establishment of 6 pediatric rhabdomyosarcoma patient's derived xenograft models closely recapitulating patients' tumor characteristics.
Gasparini P; Casanova M; Centonze G; Borzi C; Bergamaschi L; Collini P; Testi A; Chiaravalli S; Massimino M; Sozzi G; Ferrari A; Moro M
Tumori; 2023 Jun; 109(3):314-323. PubMed ID: 36114629
[TBL] [Abstract][Full Text] [Related]
23. Patient-Derived Xenograft Models in Cancer Research: Methodology, Applications, and Future Prospects.
Aslani S; Saad MI
Methods Mol Biol; 2024; 2806():9-18. PubMed ID: 38676792
[TBL] [Abstract][Full Text] [Related]
24. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
[TBL] [Abstract][Full Text] [Related]
25. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
Paez-Ribes M; Man S; Xu P; Kerbel RS
PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
[TBL] [Abstract][Full Text] [Related]
26. Mouse avatars of human cancers: the temporality of translation in precision oncology.
Green S; Dam MS; Svendsen MN
Hist Philos Life Sci; 2021 Feb; 43(1):27. PubMed ID: 33620596
[TBL] [Abstract][Full Text] [Related]
27. Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
Lawrence MG; Pook DW; Wang H; Porter LH; Frydenberg M; Kourambas J; Appu S; Poole C; Beardsley EK; Ryan A; Norden S; Papargiris MM; Risbridger GP; Taylor RA
Prostate; 2015 Sep; 75(13):1475-83. PubMed ID: 26177841
[TBL] [Abstract][Full Text] [Related]
28. Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.
He F; Bandyopadhyay AM; Klesse LJ; Rogojina A; Chun SH; Butler E; Hartshorne T; Holland T; Garcia D; Weldon K; Prado LP; Langevin AM; Grimes AC; Sugalski A; Shah S; Assanasen C; Lai Z; Zou Y; Kurmashev D; Xu L; Xie Y; Chen Y; Wang X; Tomlinson GE; Skapek SX; Houghton PJ; Kurmasheva RT; Zheng S
Nat Commun; 2023 Nov; 14(1):7600. PubMed ID: 37990009
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
[TBL] [Abstract][Full Text] [Related]
30. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.
Stacchiotti S; Saponara M; Frapolli R; Tortoreto M; Cominetti D; Provenzano S; Negri T; Dagrada GP; Gronchi A; Colombo C; Vincenzi B; Badalamenti G; Zuco V; Renne SL; Collini P; Morosi C; Dei Tos AP; Bello E; Pilotti S; Casali PG; D'Incalci M; Zaffaroni N
Eur J Cancer; 2017 May; 76():84-92. PubMed ID: 28284173
[TBL] [Abstract][Full Text] [Related]
31. Patient-derived xenograft models of breast cancer and their predictive power.
Whittle JR; Lewis MT; Lindeman GJ; Visvader JE
Breast Cancer Res; 2015 Feb; 17(1):17. PubMed ID: 25849559
[TBL] [Abstract][Full Text] [Related]
32. Patient derived xenografts as models for head and neck cancer.
Nitschinsk K; Idris A; McMillan N
Cancer Lett; 2018 Oct; 434():114-119. PubMed ID: 30031118
[TBL] [Abstract][Full Text] [Related]
33. Breast Cancer Xenograft Murine Models.
Fernando W; Coyle KM; Marcato P
Methods Mol Biol; 2022; 2508():31-44. PubMed ID: 35737231
[TBL] [Abstract][Full Text] [Related]
34. Patient-derived xenografts: a relevant preclinical model for drug development.
Pompili L; Porru M; Caruso C; Biroccio A; Leonetti C
J Exp Clin Cancer Res; 2016 Dec; 35(1):189. PubMed ID: 27919280
[TBL] [Abstract][Full Text] [Related]
35. Modeling of Patient-Derived Xenografts in Colorectal Cancer.
Katsiampoura A; Raghav K; Jiang ZQ; Menter DG; Varkaris A; Morelli MP; Manuel S; Wu J; Sorokin AV; Rizi BS; Bristow C; Tian F; Airhart S; Cheng M; Broom BM; Morris J; Overman MJ; Powis G; Kopetz S
Mol Cancer Ther; 2017 Jul; 16(7):1435-1442. PubMed ID: 28468778
[TBL] [Abstract][Full Text] [Related]
36. Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.
Pan CX; Zhang H; Tepper CG; Lin TY; Davis RR; Keck J; Ghosh PM; Gill P; Airhart S; Bult C; Gandara DR; Liu E; de Vere White RW
PLoS One; 2015; 10(8):e0134346. PubMed ID: 26270481
[TBL] [Abstract][Full Text] [Related]
37. Fidelity of a PDX-CR model for bladder cancer.
Mondal AM; Ma AH; Li G; Krawczyk E; Yuan R; Lu J; Schlegel R; Stamatakis L; Kowalczyk KJ; Philips GK; Pan CX; Liu X
Biochem Biophys Res Commun; 2019 Sep; 517(1):49-56. PubMed ID: 31303270
[TBL] [Abstract][Full Text] [Related]
38. PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients.
Kim Y; Kim D; Cao B; Carvajal R; Kim M
BMC Bioinformatics; 2020 Jul; 21(1):288. PubMed ID: 32631229
[TBL] [Abstract][Full Text] [Related]
39. Patient-Derived Xenograft Models of Colorectal Cancer: Procedures for Engraftment and Propagation.
Burgenske DM; Monsma DJ; MacKeigan JP
Methods Mol Biol; 2018; 1765():307-314. PubMed ID: 29589317
[TBL] [Abstract][Full Text] [Related]
40. Patient-derived xenografts as tools in pharmaceutical development.
Izumchenko E; Meir J; Bedi A; Wysocki PT; Hoque MO; Sidransky D
Clin Pharmacol Ther; 2016 Jun; 99(6):612-21. PubMed ID: 26874468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
